Page 18 - Cell Host News Today

Researchers highlighted the role of lipids, especially bacteria-derived lipids in the gut microbiome, in mammalian physiology in the context of immunity and metabolism. Note that commensal fungal species also produce lipid metabolites.

CLAIM: Dr. Anthony Fauci, in a recent science paper, admits that COVID-19 vaccines don’t work. AP’S ASSESSMENT: False. The scientific journal article doesn’t say the vaccines don’t work.

Anthony Fauci ended up looking arrogant and narcissistic when he was making demands that Americans wear COVID masks, take experimental shots and such during the pandemic.

The study was led by scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health, as part of the Center for Solutions for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

/PRNewswire/ -- For decades, people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have faced multiple obstacles. The most immediate are...

Anthony Fauci knows why COVID-19 vaccines have been so unreliable at halting infection and transmission beyond a few months. He waited until he stepped down as director of the National Institute of Al...

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).

Researchers at Mount Sinai, in collaboration with researchers at New York University, have published a study in Cell Host and Microbe that sheds light on the mechanisms behind the severity, or virulence, of methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections.

In a recent review, the former director of the National Institute of Allergy and Infectious Diseases and former chief medical advisor to the president of the United States (U.S.), Dr. Fauci, and his team review the roadblocks to developing effective vaccines against viruses that infect the human respiratory mucosa and discuss strategies for next-generation vaccine development against mucosal respiratory viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.